HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrey Anisimov Selected Research

TIE Receptors (TIE Receptor Tyrosine Kinases)

1/2022Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression.
1/2016Tie1 controls angiopoietin function in vascular remodeling and inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrey Anisimov Research Topics

Disease

6Neoplasms (Cancer)
01/2016 - 12/2010
5Inflammation (Inflammations)
01/2021 - 10/2010
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2018 - 10/2010
3Ischemia
01/2018 - 01/2014
3Cardiomegaly (Heart Hypertrophy)
04/2017 - 10/2010
3Hypertrophy
10/2015 - 10/2010
2Hypoxia (Hypoxemia)
01/2018 - 08/2012
2Neoplasm Metastasis (Metastasis)
08/2013 - 03/2012
1Lymphedema (Milroy Disease)
01/2022
1Adenoma (Adenomas)
01/2021
1Obesity
01/2021
1Reperfusion Injury
04/2017
1Infarction (Infarctions)
04/2017
1Vascular Remodeling
01/2016
1Plague (Bubonic Plague)
01/2016
1Aneurysm (Aneurysms)
12/2014
1Rupture
12/2014
1Thrombosis (Thrombus)
12/2014
1Neointima
12/2014
1Ruptured Aneurysm
12/2014
1Chylothorax
02/2014
1Heart Diseases (Heart Disease)
01/2014
1Pathologic Processes
08/2013
1Edema (Dropsy)
08/2013
1Necrosis
06/2013
1Hemangioma (Angioma)
01/2013
1Heart Failure
12/2012
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2012
1Pathologic Neovascularization
02/2010

Drug/Important Bio-Agent (IBA)

6Vascular Endothelial Growth Factor CIBA
01/2022 - 02/2010
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 10/2010
4Vascular Endothelial Growth Factor BIBA
04/2017 - 10/2010
3AngiopoietinsIBA
01/2022 - 02/2014
3Vascular Endothelial Growth FactorsIBA
08/2013 - 12/2010
2TIE Receptors (TIE Receptor Tyrosine Kinases)IBA
01/2022 - 01/2016
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2015 - 10/2010
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2014 - 02/2010
2Blocking AntibodiesIBA
02/2014 - 12/2010
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
08/2013 - 02/2010
2Placenta Growth FactorIBA
08/2013 - 10/2010
2LigandsIBA
03/2012 - 12/2010
2AntibodiesIBA
03/2012 - 12/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2021
1CollagenIBA
01/2021
1Transforming Growth Factor beta (TGF-beta)IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2018
1LipidsIBA
01/2018
1p-Methoxy-N-methylphenethylamineIBA
01/2018
1Chymases (Chymase)IBA
01/2018
1Troponin T (Troponin T1)IBA
04/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1Angiotensin IIIBA
10/2015
1Tyrosine Kinase InhibitorsIBA
10/2015
1Therapeutic UsesIBA
10/2015
1Phosphotransferases (Kinase)IBA
10/2015
13,3'- dioactadecyl- 5,5'- di(4- sulfophenyl)oxacarbocyanineIBA
12/2014
1Phenobarbital (Luminal)FDA Link
12/2014
1FibrinIBA
12/2014
1PolymersIBA
12/2014
1Trans-Activators (Trans-Acting Factor)IBA
02/2014
1Tetracycline (Achromycin)FDA LinkGeneric
02/2014
1Doxycycline (Periostat)FDA LinkGeneric
02/2014
1UteroglobinIBA
02/2014
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
06/2013
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2013
1Vascular Endothelial Growth Factor DIBA
12/2012
1Pharmaceutical PreparationsIBA
08/2012
1Transcription Factors (Transcription Factor)IBA
08/2012
1TIE-2 Receptor (Receptor, TIE 2)IBA
03/2012
1Angiopoietin-2IBA
03/2012
1Protein Isoforms (Isoforms)IBA
10/2010
1human VEGFB proteinIBA
10/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2010
1Neuropilin-1IBA
10/2010

Therapy/Procedure

2Therapeutics
02/2014 - 12/2010
1Transplantation
12/2014
1Cell Transplantation
12/2014
1Drug Therapy (Chemotherapy)
08/2012
1Intravenous Injections
03/2012